⚠️Drugmakers have been warned that the Trump administration is considering tying U.S. drug prices to the lower amounts paid in other developed countries, a top concern for the pharmaceutical industry, according to pharmaceutical company sources. Such a policy would have a greater impact on the pharmaceutical industry, and it is the biggest existential threat to the industry and U.S. bioscience innovation.